SCHEMBL317184

SCHEMBL317184

O=C(F)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
HTT P42858 3/20 0.40
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
GAA P10253 1/20 0.36
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 2/20 0.32
RECQL P46063 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA4 P22748 2/20 0.32
HDAC3 O15379 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1900629 0.96 CES2 (0.39) CES2CES1HTTLMNATP53
SCHEMBL6448128 0.93 CES2 (0.43) CES2CES1HTTLMNATP53
SCHEMBL9748198 0.84 TAS1R3 (0.44) CES2CES1HTTPKMSMN1; SMN2
SCHEMBL9320500 0.82 CES2 (0.32) CES2CES1HTT
SCHEMBL10937999 0.80 SMN1; SMN2 (0.41) CES2CES1HTTSMN1; SMN2TSHR
SCHEMBL11255943 0.80 CES2 (0.52) CES2CES1HTTLMNATP53
SCHEMBL10709506 0.80 CES2 (0.46) CES2CES1
SCHEMBL10710744 0.78 CES2 (0.56) CES2CES1HTTCA1CA2
SCHEMBL9073432 0.78 SMN1; SMN2 (0.44) CES2CES1SMN1; SMN2TSHRMEN1
SCHEMBL11263582 0.78 CES2 (0.56) CES2CES1HTTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217897-A Polyelectrolyte material, preparation method thereof and cation selective separation membrane 中国科学技术大学 2023-06-06 CN claimed
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 US claimed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 US claimed
EP-3038621-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR Human Biomolecular Research Institute (US) 2016-07-06 EP claimed
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2016-02-11 US claimed
WO-2014146039-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2014-09-18 WO claimed
WO-2025132776-A1 USE OF IRON-BASED COMPOUNDS FOR THE SYNTHESIS OF BORATED COMPOUNDS, AND CORRESPONDING METHODS Universite Paris-Saclay (FR) 2025-06-26 WO disclosed
EP-4543895-A1 NOVEL IRON-BASED COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF AS CATALYSTS Université Paris-Saclay (FR) 2025-04-30 EP disclosed
CN-119816509-A Novel iron-based compounds, method for the production thereof and use thereof as catalysts 巴黎萨克雷大学 2025-04-11 CN disclosed
US-11977084-B2 Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides THE JOHNS HOPKINS UNIVERSITY (US) 2024-05-07 US disclosed
WO-2023247697-A1 NOVEL IRON-BASED COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF AS CATALYSTS Universite Paris-Saclay (FR) 2023-12-28 WO disclosed
WO-2023227577-A1 HYDROPHILIC COATINGS FOR VASCULAR MEDICAL PRODUCTS BIOTRONIK AG (CH) 2023-11-30 WO disclosed
CN-116217897-A Polyelectrolyte material, preparation method thereof and cation selective separation membrane 中国科学技术大学 2023-06-06 CN disclosed
EP-0067851-A4 FLUORINATED MONOPHENOLS AND DIPHENOLS AND METHOD FOR THEIR PREPARATION. GEN ELECTRIC (US) 1983-06-09 EP disclosed
EP-0067851-A1 FLUORINATED MONOPHENOLS AND DIPHENOLS AND METHOD FOR THEIR PREPARATION GENERAL ELECTRIC COMPANY (US) 1982-12-29 EP disclosed
US-4358624-A FLUOROPOLYMERS; POLYCARBONATES; FIREPROOFING GENERAL ELECTRIC COMPANY (US) 1982-11-09 US disclosed
WO-1982002380-A1 FLUORINATED MONOPHENOLS AND DIPHENOLS AND METHOD FOR THEIR PREPARATION GEN ELECTRIC (US) 1982-07-22 WO disclosed
EP-0023647-B1 Process for the preparation of halogenated benzoyl fluorides BAYER AG (DE) 1982-06-30 EP disclosed
US-4330366-A Process for the preparation of halogenated benzoyl fluorides BAYER AKTIENGESELLSCHAFT (DE) 1982-05-18 US disclosed
EP-0023647-A1 Process for the preparation of halogenated benzoyl fluorides BAYER AG (DE) 1981-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11596716-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 CES2 4108/4885CES1 4462/4885HTT 4875/4885
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 CES2 4108/4885CES1 4462/4885HTT 4875/4885
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 CES2 4063/4885CES1 4830/4885HTT 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.